Associate Professor Nada   Hamad
Conjoint Senior Lecturer

Associate Professor Nada Hamad

BSc MSc Forensic (hons) MBBS (hons) FRACP FRCPA SpeCetClinRes (Oncology)

medicine-health
St Vincent's Clinical School

A/Prof Nada Hamad is a senior staff specialist bone marrow transpalnt, clinical and laboratory haematologist at St Vincent’s hospital in Sydney, where she is also director of the haematology clinical trials unit. She is President of the Bone Marrow Transplant Society of Australia and New Zealand, Chair of the ACI NSW BMT network and Chair of ALLG BMTCT working group.  She is a senior lecturer at the University of Sydney and University of NSW. Dr Hamad studied Medicine at the University of Sydney and completed her Haematology training in Sydney. Prior to her career in medicine, she completed a Bachelor of Science and Master of Science in Forensics, working in this field for a short period of time.  She completed two post-graduate fellowships in BMT and lymphoma at the Princess Margaret Cancer Centre in Toronto Canada through the University of Toronto. She has a strong interest in clinical trials, has a specialist certificate in Clinical Research (Oncology) from the University of Melbourne and is an active member of the Australasian Leukaemia and Lymphoma Group (ALLG) as a member of a number of disease group committees. Her clinical research interests are in malignant haematology and bone marrow transplantation.

Phone
61 2 93555656
Location
Senior Staff Specialist BMT, Clinical and Laboratory Haematologist Director of Haematology Clinical Trials Unit St. Vincents Health Network, Kinghorn Cancer Centre 370 Victoria St, Darlinghurst, NSW 2010

Publications

  • Journal articles | 2021
    Associate Professor Nada Hamad
    McCaughan G; Di Ciaccio P; Ananda-Rajah M; Gilroy N; MacIntyre R; Teh B; Weinkove R; Curnow J; Szer J; Enjeti AK; Ross DM; Mulligan S; Trotman J; Dickinson M; Quach H; Choi P; Polizzotto MN; Tam CS; Ho PJ; Ku M; Gregory G; Gangatharan S; Hapgood G; Cochrane T; Cheah C; Gibbs S; Wei A; Johnston A; Greenwood M; Prince HM; Latimer M; Berkahn L; Wight J; Armytage T; Hamad N, 2021, 'COVID-19 vaccination in haematology patients: an Australian and New Zealand consensus position statement', Internal Medicine Journal, vol. 51, pp. 763 - 768, http://dx.doi.org/10.1111/imj.15247
    Journal articles | 2021
    Associate Professor Nada Hamad
    Scordo M; Wang TP; Ahn KW; Chen Y; Ahmed S; Awan FT; Beitinjaneh A; Chen A; Chow VA; Dholaria B; Epperla N; Farooq U; Ghosh N; Grover N; Hamad N; Hildebrandt GC; Holmberg L; Hong S; Inwards DJ; Jimenez-Jimenez A; Karmali R; Kenkre VP; Khimani F; Klyuchnikov E; Krem MM; Munshi PN; Nieto Y; Prestidge T; Ramakrishnan Geethakumari P; Rezvani AR; Riedell PA; Seo S; Shah NN; Solh M; Yared JA; Kharfan-Dabaja MA; Herrera A; Hamadani M; Sauter CS, 2021, 'Outcomes Associated with Thiotepa-Based Conditioning in Patients with Primary Central Nervous System Lymphoma after Autologous Hematopoietic Cell Transplant', JAMA Oncology, vol. 7, pp. 993 - 1003, http://dx.doi.org/10.1001/jamaoncol.2021.1074
    Journal articles | 2021
    Associate Professor Nada Hamad
    MacIntyre CR; Veness B; Berger D; Hamad N; Bari N, 2021, 'Thrombosis with Thrombocytopenia Syndrome (TTS) following AstraZeneca ChAdOx1 nCoV-19 (AZD1222) COVID-19 vaccination – A risk–benefit analysis for people < 60 years in Australia', Vaccine, http://dx.doi.org/10.1016/j.vaccine.2021.07.013
    Journal articles | 2021
    Associate Professor Nada Hamad
    Lewis KL; Chin CK; Manos K; Casey J; Hamad N; Crawford J; Ho SJ; Issa S; Grigg A; Wood P; Gandhi MK; Do B; Nastoupil L; Hawkes EA; Cheah CY, 2021, 'Ibrutinib for central nervous system lymphoma: the Australasian Lymphoma Alliance/MD Anderson Cancer Center experience', British Journal of Haematology, vol. 192, pp. 1049 - 1053, http://dx.doi.org/10.1111/bjh.16946
    Journal articles | 2021
    Associate Professor Nada Hamad
    Casasnovas R-O; Follows G; Zijlstra JM; Vermaat JSP; Kalakonda N; Choquet S; Neste EVD; Hill B; Thieblemont C; Cavallo F; la Cruz FD; Kuruvilla J; Hamad N; Jaeger U; Caimi PF; Gurion R; Warzocha K; Bakhshi S; Sancho J-M; Schuster M; Egyed M; Offner F; Vassilakopoulos TP; Samal P; Ku M; Ma X; Chamoun K; Shah J; Canales M; Maerevoet M; Shacham S; Kauffman MG; Goy A, 2021, 'Comparison of the effectiveness and safety of the oral selective inhibitor of nuclear export, selinexor, in diffuse large B cell lymphoma subtypes', Clinical Lymphoma Myeloma and Leukemia, http://dx.doi.org/10.1016/j.clml.2021.07.017
    Journal articles | 2021
    Associate Professor Nada Hamad
    Tang C; Hamad N, 2021, 'Trials and tribulations: including women in cancer clinical research', The Lancet Haematology, vol. 8, pp. e477 - e478, http://dx.doi.org/10.1016/S2352-3026(21)00165-4
    Journal articles | 2021
    Associate Professor Nada Hamad
    Shah J; Shacham S; Kauffman M; Daniele P; Tomaras D; Tremblay G; Casasnovas RO; Maerevoet M; Zijlstra J; Follows G; P Vermaat JS; Kalakonda N; Goy AH; Choquet S; Den Neste EV; Hill BT; Thieblemont C; Cavallo F; La Cruz FD; Kuruvilla J; Hamad N; Bouabdallah R; Jäger U; Caimi P; Gurion R; Warzocha K; Bakhshi S; Sancho JM; Schuster M; Egyed M; Offner F; Vasilakopoulos TP; Samal P; Nagy A; Ku M; Canales Albendea MÁ, 2021, 'Health-related quality of life and utility outcomes with selinexor in relapsed/refractory diffuse large B-cell lymphoma', Future Oncology, vol. 17, pp. 1295 - 1310, http://dx.doi.org/10.2217/fon-2020-0946
    Journal articles | 2021
    Associate Professor Nada Hamad
    Ross DM; Thomson C; Hamad N; Lane SW; Manos K; Grigg AP; Guo B; Erber WN; Scott A; Viiala N; Chee L; Latimer M; Tate C; Grove C; Perkins AC; Blombery P, 2021, 'Myeloid somatic mutation panel testing in myeloproliferative neoplasms', Pathology, vol. 53, pp. 339 - 348, http://dx.doi.org/10.1016/j.pathol.2021.01.003
    Journal articles | 2021
    Associate Professor Nada Hamad
    Blennerhassett R; Purtill D; Hamad N, 2021, 'Letter to the Editor Regarding “Hematopoietic Cell Transplantation with Cryopreserved Grafts for Severe Aplastic Anemia”', Transplantation and Cellular Therapy, vol. 27, pp. 190 - 191, http://dx.doi.org/10.1016/j.jtct.2020.11.011
    Journal articles | 2021
    Associate Professor Nada Hamad
    Maerevoet M; Zijlstra JM; Follows G; Casasnovas RO; Vermaat JSP; Kalakonda N; Goy A; Choquet S; Van Den Neste E; Hill B; Thieblemont C; Cavallo F; De la Cruz F; Kuruvilla J; Hamad N; Jaeger U; Caimi P; Gurion R; Warzocha K; Bakhshi S; Sancho JM; Schuster M; Egyed M; Offner F; Vassilakopoulos TP; Samal P; Ku M; Ma X; Corona K; Chamoun K; Shah J; Shacham S; Kauffman MG; Canales M, 2021, 'Survival among patients with relapsed/refractory diffuse large B cell lymphoma treated with single-agent selinexor in the SADAL study', Journal of Hematology and Oncology, vol. 14, http://dx.doi.org/10.1186/s13045-021-01122-1
    Journal articles | 2021
    Associate Professor Nada Hamad
    Connolly EA; Weickhardt AJ; Grimison PS; Heller G; Lewin JH; Liow ECH; Tung I; Tran B; Hill S; Walpole ET; McKenzie J; Kuchel A; Forgeson G; Tan ABT; Joshi A; Wickham A; Tan TH; Wang Y; Hamad N; Wong V, 2021, 'Australia and New Zealand (ANZ) outcomes of high-dose chemotherapy and stem cell transplantation for relapsed or refractory germ cell tumors (GCT) from 1999 to 2019: Multicenter registry-based study with ABMTRR.', Journal of Clinical Oncology, vol. 39, pp. 382 - 382, http://dx.doi.org/10.1200/jco.2021.39.6_suppl.382
    Journal articles | 2021
    Associate Professor Nada Hamad
    Di Ciaccio PR; Greenwood M; Kennedy G; Milliken S; Gottlieb D; Ritchie DS; Purtill D; Larsen SR; Spencer A; Perera T; Yeung DT; Durrant S; Butler A; Watson A-M; Lai HC; Doocey RT; Goodman HJ; Kerridge IH; Arthur C; Curley C; Stewart C; Micklethwaite K; Collins J; Cooney JP; Hamad N, 2021, 'Allogeneic Stem Cell Transplantation for Diffuse Large B Cell Lymphoma Can Achieve Durable Remissions: An Australasian Bone Marrow Transplant Recipient Registry Study', Transplantation and Cellular Therapy, vol. 27, pp. S394 - S394, http://dx.doi.org/10.1016/s2666-6367(21)00508-x
    Journal articles | 2021
    Associate Professor Nada Hamad
    Barge L; Tran S; Kennedy G; Ritchie DS; Gottlieb D; Milliken S; Spencer A; Purtill D; Perera T; Doocey RT; Larsen S; Butler A; Bardy P; Greenwood M; Durrant S; Curley C; Stewart C; Tam CS; Collins J; Balendran S; Di Ciaccio PR; Patil S; Han M-H; Hamad N, 2021, 'Improvement in Non-Relapse Mortality Following Allogeneic Transplantation for Chronic Lymphocytic Leukaemia in Australia and New Zealand: An Australasian Bone Marrow Transplant Recipient Registry Study', Transplantation and Cellular Therapy, vol. 27, pp. S133 - S135, http://dx.doi.org/10.1016/s2666-6367(21)00168-8
    Journal articles | 2021
    Associate Professor Nada Hamad
    Di Ciaccio PR; Ritchie DS; Kennedy G; Milliken S; Purtill D; Gottlieb D; Perera T; Yeung DT; Larsen SR; Doocey RT; Greenwood M; Durrant S; Watson A-M; Butler A; Khot A; Curley C; Hamad N, 2021, 'Allogeneic Haematopoietic Cell Transplantation for Mantle Cell Lymphoma Can Achieve Durable Remission and Myeloablative Conditioning Is Associated with Inferior Survival: An Australasian Bone Marrow Transplant Recipient Registry Study', Transplantation and Cellular Therapy, vol. 27, pp. S394 - S395, http://dx.doi.org/10.1016/s2666-6367(21)00509-1
    Journal articles | 2020
    Associate Professor Nada Hamad
    Cashman H; Mayson E; Kliman D; Kesby J; Bell J; Vachalec S; Withers B; Lavee O; Milliken S; Moore J; Hamad N, 2020, 'An integrated electronic health record facilitates a safer and more efficient rural outreach haematology service', Internal Medicine Journal, http://dx.doi.org/10.1111/imj.14973
    Journal articles | 2020
    Associate Professor Nada Hamad
    Kalakonda N; Maerevoet M; Cavallo F; Follows G; Goy A; Vermaat JSP; Casasnovas O; Hamad N; Zijlstra JM; Bakhshi S; Bouabdallah R; Choquet S; Gurion R; Hill B; Jaeger U; Manuel Sancho J; Schuster M; Thieblemont C; De la Cruz F; Egyed M; Mishra S; Offner F; Vassilakopoulos TP; Warzocha K; McCarthy D; Ma X; Corona K; Saint-Martin J-R; Chang H; Landesman Y; Joshi A; Wang H; Shah J; Shacham S; Kauffman M; Van den Neste E; Canales MA, 2020, 'Selinexor in patients with relapsed or refractory diffuse large B -cell lymphoma (SADAL): a single -arm, multinational, multicentre, open -label, phase 2 trial', LANCET HAEMATOLOGY, vol. 7, pp. E509 - E522, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000544758900006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2020
    Associate Professor Nada Hamad
    Kalakonda N; Maerevoet M; Cavallo F; Follows G; Goy A; Vermaat JSP; Casasnovas O; Hamad N; Zijlstra JM; Bakhshi S; Bouabdallah R; Choquet S; Gurion R; Hill B; Jaeger U; Sancho JM; Schuster M; Thieblemont C; De la Cruz F; Egyed M; Mishra S; Offner F; Vassilakopoulos TP; Warzocha K; McCarthy D; Ma X; Corona K; Saint-Martin JR; Chang H; Landesman Y; Joshi A; Wang H; Shah J; Shacham S; Kauffman M; Van Den Neste E; Canales MA, 2020, 'Selinexor in patients with relapsed or refractory diffuse large B-cell lymphoma (SADAL): a single-arm, multinational, multicentre, open-label, phase 2 trial', The Lancet Haematology, vol. 7, pp. e511 - e522, http://dx.doi.org/10.1016/S2352-3026(20)30120-4
    Journal articles | 2020
    Associate Professor Nada Hamad
    Casasnovas RO; Daniele P; Tremblay G; Maerevoet M; Zijlstra J; Follows G; Vermaat JSP; Kalakonda N; Goy AH; Choquet S; Van Den Neste E; Hill BT; Thieblemont C; Cavallo F; de la Cruz F; Kuruvilla J; Hamad N; Bouabdallah R; Jäger U; Caimi P; Gurion R; Warzocha K; Bakhshi S; Sancho JM; Schuster M; Egyed M; Offner F; Vasilakopoulos T; Samal P; Nagy A; Ku M; Canales Albendea MÁ, 2020, 'PCN325 Health Utility in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (RR-DLBCL) Patients - Results of a Phase II Trial with ORAL Selinexor', Value in Health, vol. 23, pp. S479 - S480, http://dx.doi.org/10.1016/j.jval.2020.08.462
    Journal articles | 2020
    Associate Professor Nada Hamad
    Purtill D; Antonenas V; Chiappini P; Tong D; O’Flaherty E; Bajel A; Kabani K; Larsen S; Tan S; Hutchins C; Curtis DJ; Kennedy GA; Watson AM; Bai LJ; Greenwood M; Gottlieb DJ; Hamad N, 2020, 'Variable CD341 recovery of cryopreserved allogeneic HPC products: Transplant implications during the COVID-19 pandemic', Blood Advances, vol. 4, pp. 4147 - 4150, http://dx.doi.org/10.1182/bloodadvances.2020002431
    Journal articles | 2020
    Associate Professor Nada Hamad
    Di Ciaccio P; McCaughan G; Trotman J; Ho PJ; Cheah CY; Gangatharan S; Wight J; Ku M; Quach H; Gasiorowski R; Polizzotto MN; Prince HM; Mulligan S; Tam CS; Gregory G; Hapgood G; Spencer A; Dickinson M; Latimer M; Johnston A; Armytage T; Lee C; Cochrane T; Berkhahn L; Weinkove R; Doocey R; Harrison SJ; Webber N; Lee HP; Chapman S; Campbell BA; Gibbs SDJ; Hamad N, 2020, 'Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID-19 pandemic', Internal Medicine Journal, vol. 50, pp. 667 - 679, http://dx.doi.org/10.1111/imj.14859
    Journal articles | 2020
    Associate Professor Nada Hamad
    Hamad N; Gottlieb D; Ritchie D; Kennedy G; Watson AM; Greenwood M; Doocey R; Perera T; Spencer A; Wong E; O'Brien T; Shaw P; Conyers R; Cole T; Milliken S; Bardy P; Larsen S; Lai H; Butler A; Fraser C; Bajel A; Butler J; Kerridge I; Purtill D, 2020, 'Bone Marrow Transplant Society of Australia and New Zealand COVID-19 consensus position statement', Internal Medicine Journal, vol. 50, pp. 774 - 775, http://dx.doi.org/10.1111/imj.14867
    Journal articles | 2020
    Associate Professor Nada Hamad
    Lwin Y; Kennedy G; Gottlieb D; Kwan J; Ritchie D; Szer J; Milliken S; Browett P; Spencer A; Butler A; Bardy P; Greenwood M; Perera T; He S; McEwan A; Larsen S; Lai H; Purtill D; Tran S; Aarons D; Hamad N, 2020, 'Australasian Trends in Allogeneic Stem Cell Transplantation for Myelofibrosis in the Molecular Era: A Retrospective Analysis from the Australasian Bone Marrow Transplant Recipient Registry', Biology of Blood and Marrow Transplantation, vol. 26, pp. 2252 - 2261, http://dx.doi.org/10.1016/j.bbmt.2020.08.024
    Journal articles | 2020
    Associate Professor Nada Hamad
    Othman J; Greenwood M; Moore J; Larsen S; Watson AM; Arthur C; Bhattacharyya A; Bilmon I; Blyth E; Bryant A; Bryant C; Dunlop L; Fay K; Gibson J; Hamad N; Kerridge I; Kwan J; Ma D; Micklethwaite K; Milliken S; Panicker S; Stevenson W; Withers B; Wilcox L; Tran S; Gottlieb DJ, 2020, 'Unrelated Donor Transplant Recipients Given Thymoglobuline Have Superior GRFS When Compared to Matched Related Donor Recipients Undergoing Transplantation without ATG', Biology of Blood and Marrow Transplantation, vol. 26, pp. 1868 - 1875, http://dx.doi.org/10.1016/j.bbmt.2020.06.030
    Journal articles | 2020
    Associate Professor Nada Hamad
    Kliman D; Nivison-Smith I; Gottlieb D; Hamad N; Kerridge I; Purtill D; Szer J; Ma D, 2020, 'Hematopoietic Stem Cell Transplant Recipients Surviving at Least 2 Years from Transplant Have Survival Rates Approaching Population Levels in the Modern Era of Transplantation', Biology of Blood and Marrow Transplantation, vol. 26, pp. 1711 - 1718, http://dx.doi.org/10.1016/j.bbmt.2020.03.005
    Journal articles | 2020
    Associate Professor Nada Hamad
    Cashman H; Mayson E; Kliman D; Vachalec S; Bell J; Milliken S; Moore J; Lavee O; Withers B; Hamad N, 2020, 'A Shared Electronic Health Record in a Rural Setting Maintains Hematological Cancer Services Remotely during the COVID-19 Pandemic', Blood, vol. 136, pp. 5 - 5, http://dx.doi.org/10.1182/blood-2020-142209
    Journal articles | 2020
    Associate Professor Nada Hamad
    Wang J; Asch AS; Hamad N; Weickhardt A; Tomaszewska-Kiecana M; Dlugosz-Danecka M; Pylypenko H; Bahadur S; Ulahannan S; Koucheki J; Sun J; Li H; Chen F; Zhang X; Muth J; Kaminker P; Moore P; Sumrow BJ, 2020, 'A Phase 1, Open-Label Study of MGD013, a Bispecific DART® Molecule Binding PD-1 and LAG-3 in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma', Blood, vol. 136, pp. 21 - 22, http://dx.doi.org/10.1182/blood-2020-139868
    Journal articles | 2020
    Associate Professor Nada Hamad
    Boyle S; Tobin JWD; Perram J; Hamad N; Barraclough A; Singaraveloo L; Han M-H; Blennerhassett R; Nelson NE; Johnston A; Talaulikar D; Karpe K; Bhattacharyya A; Cheah CY; Subramoniapillai E; Bokhari W; Lee C; Hawkes EA; Gullapalli V; Jabbour A; Strasser S; Chadban S; Brown C; Mollee P; Hapgood G, 2020, 'Management and Outcomes of Diffuse Large B Cell Lymphoma Post-Transplant Lymphoproliferative Disorder in the PET/CT Era: A Multicentre Study from the Australasian Lymphoma Alliance', Blood, vol. 136, pp. 36 - 38, http://dx.doi.org/10.1182/blood-2020-140665
    Journal articles | 2020
    Associate Professor Nada Hamad
    White J; Hamad N; Linn SM; Novitzky-Basso IN; Abduljalil O; Law A; Kim DDH, 2020, 'Multicenter, Retrospective Evaluation of Therapeutic Efficacy of Ruxolitinib for Chronic Gvhd Treatment', Blood, vol. 136, pp. 45 - 47, http://dx.doi.org/10.1182/blood-2020-136164
    Journal articles | 2020
    Associate Professor Nada Hamad
    Minson A; Hamad N; Butler JP; Westerman DA; Ritchie D; Blombery P; Seymour JF; Tam CS; Dickinson M, 2020, 'A Phase II, Open-Label, Single Arm Trial to Assess the Efficacy and Safety of the Combination of Tisagenlecleucel and Ibrutinib in Mantle Cell Lymphoma (TARMAC)', Blood, vol. 136, pp. 34 - 35, http://dx.doi.org/10.1182/blood-2020-138946
    Journal articles | 2020
    Associate Professor Nada Hamad
    Benajiba L; Carraway HE; Hamad N; Stein EM; Yannakou CK; Burroughs A; Harris S; Lane H; Nguyen DD; Stuart M; Vargas J; Puissant A; Stegmaier K; DiNardo CD, 2020, 'Trials in Progress: A Phase I Study to Evaluate the Safety and Pharmacokinetic Profiles of CB-5339 in Participants with Relapsed/Refractory Acute Myeloid Leukemia or Relapsed/Refractory Intermediate or High-Risk Myelodysplastic Syndrome', Blood, vol. 136, pp. 21 - 21, http://dx.doi.org/10.1182/blood-2020-140636
    Journal articles | 2020
    Associate Professor Nada Hamad
    Paterson JA; Hwang A; Wong S; Sewell W; Joseph JE; Hamad N, 2020, 'Two Rare Cases of Severe Autoimmune Dyserythropoiesis without Any Underlying Haematological Malignancy or Autoimmune Disease', Blood, vol. 136, pp. 2 - 3, http://dx.doi.org/10.1182/blood-2020-142281
    Journal articles | 2020
    Associate Professor Nada Hamad
    Moore J; Kwan J; Gottlieb D; Bajel A; Ritchie D; Yeung DT; Greenwood M; Purtill D; Tran S; Aarons D; Hamad N, 2020, 'A Prospective Haploidentical Peripheral Blood Stem Cell Transplant Study Using a Pre-Defined Conditioning Regimen Intensity Based on Age and the Hematopoietic Cell Transplantation Comorbidity Index- Anzhit 1: Encouraging Preliminary Survival Outcomes at One Year Follow up', Blood, vol. 136, pp. 51 - 52, http://dx.doi.org/10.1182/blood-2020-142131
    Journal articles | 2020
    Associate Professor Nada Hamad
    McCaughan GJ; Tran S; Durrant S; Harrison SJ; Morton J; Horvath N; Spencer A; Kerridge IH; Er JAK; Barge L; Bryant A; Filshie RJ; Choong E; Lai HC; Tiley C; Mills AK; Butler A; Moore J; Hertzberg M; Kennedy GA; Ho PJ; Sidiqi MH; Bashford J; Routledge D; Taylor K; Lee CH; Kalff A; Xia W; Hamad N, 2020, 'Trends in Outcomes in Australia and New Zealand in Autologous Stem Cell Transplantation in Older Patients with Multiple Myeloma: An Australasian Bone Marrow Transplant Recipient Registry Study', Blood, vol. 136, pp. 11 - 12, http://dx.doi.org/10.1182/blood-2020-138991
    Journal articles | 2020
    Associate Professor Nada Hamad
    Nivison-Smith I; Bajel A; Dodds AJ; Gottlieb D; Hamad N; Kennedy G; Kerridge I; David DF; Milliken S; Moore J; Purtill D; Szer J, 2020, 'Effect of donor age on adult unrelated donor hematopoietic cell transplant outcome: the Australian experience.', Intern Med J, http://dx.doi.org/10.1111/imj.15128
    Journal articles | 2019
    Associate Professor Nada Hamad
    Park JH; Woo YM; Youm EM; Hamad N; Won HH; Naka K; Park EJ; Park JH; Kim HJ; Kim SH; Kim HJ; Ahn JS; Sohn SK; Moon JH; Jung CW; Park S; Lipton JH; Kimura S; Kim JW; Kim DH, 2019, 'HMGCLL1 is a predictive biomarker for deep molecular response to imatinib therapy in chronic myeloid leukemia', Leukemia, vol. 33, pp. 1439 - 1450, http://dx.doi.org/10.1038/s41375-018-0321-8
    Journal articles | 2019
    Associate Professor Nada Hamad
    Gerstl B; Sullivan E; Koch J; Wand H; Ives A; Mitchell R; Hamad N; Anazodo A, 2019, 'Reproductive outcomes following a stem cell transplant for a haematological malignancy in female cancer survivors: a systematic review and meta-analysis', Supportive Care in Cancer, vol. 27, pp. 4451 - 4460, http://dx.doi.org/10.1007/s00520-019-05020-8
    Journal articles | 2019
    Associate Professor Nada Hamad
    Lewis KL; Dowling M; Bavishi K; Øvlisen AK; Hamad N; Choi P; Grigg A; P'Ng S; Filshie R; Ritchie DS; Bilmon I; Prince HM; Wolf M; Hertzberg M; Chuah H; El-Galaly TC; Tam CS; Seymour JF; Cheah CY, 2019, 'CLINICAL OUTCOMES FROM VENETOCLAX BASED THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY B-CELL LYMPHOMAS', Hematological Oncology, vol. 37, pp. 535 - 537, http://dx.doi.org/10.1002/hon.221_2631
    Journal articles | 2019
    Associate Professor Nada Hamad
    Lwin Y; He SZ-X; Spencer A; Purtill D; Mcewan A; Browett P; Butler A; Carter J; Bardy PG; Kennedy GA; Szer J; Ritchie D; Greenwood M; Larsen SR; Milliken S; Lai HC; Gottlieb D; Kwan J; Aarons D; Tran S; Hamad N, 2019, 'An Update of Australasian Trends in Allogeneic Stem Cell Transplantation for Myelofibrosis in the Molecular Era', Blood, vol. 134, pp. 5719 - 5719, http://dx.doi.org/10.1182/blood-2019-126547
    Journal articles | 2019
    Associate Professor Nada Hamad
    McCarthy R-L; McNamee N; Copelin B; Mills G; Wong S; Qiu MR; Earls P; Milliken S; Hamad N; Fay K; Lukeis R; Parker A; Moore J, 2019, 'A case series of langerhans cell histiocytosis with braf testing', Pathology, vol. 51, pp. S92 - S92, http://dx.doi.org/10.1016/j.pathol.2018.12.243
    Journal articles | 2017
    Associate Professor Nada Hamad
    Poch Martell M; Hamad N; Shin E; Moon JH; Sohn SK; Uhm J; Michelis FV; Viswabandya A; Lipton JH; Messner HA; Kim DDH, 2017, 'Distinctive clinical characteristics and favorable outcomes in patients with large granular lymphocytosis after allo-HCT: 12-year follow-up data', European Journal of Haematology, vol. 99, pp. 160 - 168, http://dx.doi.org/10.1111/ejh.12899
    Journal articles | 2017
    Associate Professor Nada Hamad
    Moon JH; Hamad N; Sohn SK; Uhm J; Alam N; Gupta V; Lipton JH; Messner HA; Seftel M; Kuruvilla J; Kim DH, 2017, 'Improved prognostic stratification power of CIBMTR risk score with the addition of absolute lymphocyte and eosinophil counts at the onset of chronic GVHD', Annals of Hematology, vol. 96, pp. 805 - 815, http://dx.doi.org/10.1007/s00277-017-2939-4
    Journal articles | 2016
    Associate Professor Nada Hamad
    Zheng Q; Cao J; Hamad N; Kim HJ; Moon JH; Sohn SK; Jung CW; Lipton JH; Kim DDH, 2016, 'Single nucleotide polymorphisms in apoptosis pathway are associated with response to imatinib therapy in chronic myeloid leukemia', Journal of Translational Medicine, vol. 14, http://dx.doi.org/10.1186/s12967-016-0837-5
    Journal articles | 2015
    Associate Professor Nada Hamad
    Hamad N; Shanavas M; Michelis FV; Uhm J; Gupta V; Seftel M; Kuruvilla J; Lipton JH; Messner HA; Kim DDH, 2015, 'Mycophenolate-based graft versus host disease prophylaxis is not inferior to methotrexate in myeloablative-related donor stem cell transplantation', American Journal of Hematology, vol. 90, pp. 392 - 399, http://dx.doi.org/10.1002/ajh.23955
    Journal articles | 2015
    Associate Professor Nada Hamad
    Hamad N; Armytage T; McIlroy K; Singh N; Ward C, 2015, 'Primary cutaneous mantle-cell lymphoma: A case report and literature review', Journal of Clinical Oncology, vol. 33, pp. e104 - e108, http://dx.doi.org/10.1200/JCO.2012.47.2829
    Journal articles | 2015
    Associate Professor Nada Hamad
    Hamad N; Kliman D; Best OG; Caramins M; Hertzberg M; Lindeman R; Porter R; Mulligan SP, 2015, 'Chronic lymphocytic leukaemia, monoclonal B-lymphocytosis and pregnancy: Five cases, a literature review and discussion of management', British Journal of Haematology, vol. 168, pp. 350 - 360, http://dx.doi.org/10.1111/bjh.13134
    Journal articles | 2015
    Associate Professor Nada Hamad
    Al-Daraiseh AA; Al Omari D; Al Hamid H; Hamad N; Althemali R, 2015, 'Effectiveness of Iphone's Touch ID: KSA Case Study', INTERNATIONAL JOURNAL OF ADVANCED COMPUTER SCIENCE AND APPLICATIONS, vol. 6, pp. 154 - 161, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000357578700022&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2014
    Associate Professor Nada Hamad
    Moon JH; Sohn SK; Lambie A; Ellis L; Hamad N; Uhm J; Gupta V; Lipton JH; Messner HA; Kuruvilla J; Kim D, 2014, 'Validation of national institutes of health global scoring system for chronic Graft-Versus-Host Disease (GVHD) according to overall and GVHD-specific survival', Biology of Blood and Marrow Transplantation, vol. 20, pp. 556 - 563, http://dx.doi.org/10.1016/j.bbmt.2014.01.010
    Journal articles | 2014
    Associate Professor Nada Hamad
    Kim D; Hamad N; Lee HG; Kamel-Reid S; Lipton JH, 2014, 'BCR/ABL level at 6 months identifies good risk CML subgroup after failing early molecular response at 3 months following imatinib therapy for CML in chronic phase', American Journal of Hematology, vol. 89, pp. 626 - 632, http://dx.doi.org/10.1002/ajh.23707
    Journal articles | 2014
    Associate Professor Nada Hamad
    Uhm J; Hamad N; Shin EM; Michelis FV; Shanavas M; Gupta V; Kuruvilla J; Lipton JH; Messner HA; Seftel M; Kim DDH, 2014, 'Incidence, risk factors, and long-term outcomes of sclerotic graft-versus-host disease after allogeneic hematopoietic cell transplantation', Biology of Blood and Marrow Transplantation, vol. 20, pp. 1751 - 1757, http://dx.doi.org/10.1016/j.bbmt.2014.07.001
    Journal articles | 2014
    Associate Professor Nada Hamad
    Hamad N; Kliman D; Best OG; Caramins M; Hertzberg M; Lindeman R; Porter R; Mulligan SP, 2014, 'Chronic lymphocytic leukaemia, monoclonal B-lymphocytosis and pregnancy: Five cases, a literature review and discussion of management', British Journal of Haematology, http://dx.doi.org/10.1111/bjh.13134
    Journal articles | 2014
    Associate Professor Nada Hamad
    Kim D; Won HH; Su S; Cheng L; Xu W; Hamad N; Uhm J; Gupta V; Kuruvilla J; Messner HA; Lipton JH, 2014, 'Risk stratification of organ-specific GVHD can be improved by single-nucleotide polymorphism-based risk models', Bone Marrow Transplantation, vol. 49, pp. 649 - 656, http://dx.doi.org/10.1038/bmt.2014.20
    Journal articles | 2014
    Associate Professor Nada Hamad
    Hamad N; Del Bel R; Messner HA; Kim D; Kuruvilla J; Lipton JH; Uhm J; Seftel M; Alam N; Xu W; Gupta V, 2014, 'Outcomes of Hematopoietic Cell Transplantation in Adult Patients with Acquired Aplastic Anemia Using Intermediate-Dose Alemtuzumab-Based Conditioning', Biology of Blood and Marrow Transplantation, vol. 20, pp. 1722 - 1728, http://dx.doi.org/10.1016/j.bbmt.2014.06.033
    Journal articles | 2013
    Associate Professor Nada Hamad
    Shanavas M; Hamad N; Michelis FV; Uhm J; Gupta V; Kuruvilla J; Messner HA; Lipton JH; Hwan Kim DD, 2013, 'Risk Factors For Chronic Eye and Mouth GVHD In Unrelated Hematopoietic Cell Transplantation: T Cell Depletion Is The Only Risk Factor Identified and Appears To Be Favorable', Blood, vol. 122, pp. 4601 - 4601, http://dx.doi.org/10.1182/blood.v122.21.4601.4601
  • Conference Papers | 2020
    Associate Professor Nada Hamad
    Di Ciaccio PR; Greenwood M; Kennedy GA; Milliken S; Gottlieb D; Ritchie D; Purtill D; Larsen SR; Spencer A; Perera T; Yeung DT; Durrant S; Butler A; Watson A-M; Lai HC; Doocey R; Goodman HJ; Kerridge IH; Arthur C; Curley C; Stewart C; Micklethwaite KP; Collins J; Cooney J; Hamad N, 2020, 'Allogeneic Stem Cell Transplantation for Diffuse Large B Cell Lymphoma Can Achieve Durable Remissions: An Australasian Bone Marrow Transplant Recipient Registry Study', in BLOOD, AMER SOC HEMATOLOGY, http://dx.doi.org/10.1182/blood-2020-139076
    Conference Papers | 2020
    Associate Professor Nada Hamad
    Barge L; Tran S; Kennedy GA; Ritchie D; Gottlieb D; Milliken S; Spencer A; Purtill D; Perera T; Doocey R; Larsen SR; Butler A; Bardy PG; Greenwood M; Durrant S; Curley C; Stewart C; Tam CS; Collins J; Bilmon I; Di Ciaccio PR; Patil SS; Han M-H; Hamad N, 2020, 'Improvement in Non-Relapse Mortality Following Allogeneic Transplantation for Chronic Lymphocytic Leukaemia in Australia and New Zealand: An Australasian Bone Marrow Transplant Recipient Registry Study', in BLOOD, AMER SOC HEMATOLOGY, http://dx.doi.org/10.1182/blood-2020-136574
    Conference Papers | 2020
    Associate Professor Nada Hamad
    Sharplin KM; Ritchie D; Gottlieb D; Bilmon I; Panicker S; Kennedy GA; Curley C; Purtill D; Cooney J; Doocey R; Berkahn L; Milliken S; Di Ciaccio PR; Bardy PG; Spencer A; Curtis DJ; Patil SS; Larsen SR; Perera T; Butler A; Greenwood M; Watson A-M; Lai HC; Wong E; Tran S; Hamad N, 2020, 'An Australasian Bone Marrow Transplant Registry (ABMTR) Study of the Trends and Outcomes of Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) in Hodgkin Lymphoma between 2009-2019: Relapse Remains the Most Common Cause of Death Post Transplantation', in BLOOD, AMER SOC HEMATOLOGY, http://dx.doi.org/10.1182/blood-2020-138684
    Conference Papers | 2020
    Associate Professor Nada Hamad
    Di Ciaccio PR; Ritchie D; Kennedy GA; Milliken S; Purtill D; Gottlieb D; Perera T; Yeung DT; Larsen SR; Doocey R; Greenwood M; Durrant S; Watson A-M; Butler A; Khot A; Curley C; Hamad N, 2020, 'Allogeneic Stem Cell Transplantation for Mantle Cell Lymphoma Can Achieve Durable Remission and Myeloablative Conditioning Is Associated with Inferior Survival: An Australasian Bone Marrow Transplant Recipient Registry Study', in BLOOD, AMER SOC HEMATOLOGY, http://dx.doi.org/10.1182/blood-2020-139057
    Conference Papers | 2020
    Associate Professor Nada Hamad
    Di Ciaccio PR; Polizzotto MN; Cwynarski K; Burton C; Jiamsakul A; Bower M; Kuruvilla J; Montoto S; McKay P; Osborne W; Milliken S; Linton K; Manos K; Kassam S; Doo NW; Watson A-M; Fedele PL; Yannakou CK; Hunt S; Renshaw H; Thakrar N; Smith A; Painter D; Maxwell A; Liu Q; Dhairyawan R; Ferguson G; Pickard K; Hamad N, 2020, 'Survival Outcomes for Plasmablastic Lymphoma: An International, Multicentre Study By the Australasian Lymphoma Alliance', in BLOOD, AMER SOC HEMATOLOGY, http://dx.doi.org/10.1182/blood-2020-134972
    Conference Papers | 2020
    Associate Professor Nada Hamad
    Manos K; Lasica M; Grigg A; Di Ciaccio PR; Wong J; Sekaran UC; Wight J; Goh Z; Jina H; Butler L; Yannakou CK; Hamad N; Gregory GP; Gangatharan SA; Cochrane T; Piper K; Churilov L; Hawkes EA, 2020, 'Prolonged Lymphopenia and Infection Risk Is Mitigated By Antimicrobial Prophylaxis in Patients with Indolent Non-Hodgkin Lymphoma (iNHL) Treated with Bendamustine +/-AntiCD20 Antibody: The Australasian Lymphoma Alliance Experience', in BLOOD, AMER SOC HEMATOLOGY, http://dx.doi.org/10.1182/blood-2020-138642
    Conference Papers | 2019
    Associate Professor Nada Hamad
    Hardefeldt P; Moore J; Milliken S; Fay K; Orly L; Mayson E; Withers B; Hamad N, 2019, 'Dose Adjusted R-EPOCH Does Not Improve Outcomes in High Grade B Cell Lymphoma with Double Expressor Status or Gain of MYC/BCL2', in BLOOD, AMER SOC HEMATOLOGY, Orlando, FL, presented at 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Orlando, FL, 07 December 2019 - 10 December 2019, http://dx.doi.org/10.1182/blood-2019-125154
    Conference Papers | 2019
    Associate Professor Nada Hamad
    Cashman H; Hamad N; Moore J; Milliken S; Lavee O; Withers B; Mayson E; Kliman D; Kesby J; Bell J; Vachalec S, 2019, 'An Electronic Health Record Facilitates a Safer and More Efficient Rural Outreach Haematology/Oncology Service', in BLOOD, AMER SOC HEMATOLOGY, Orlando, FL, presented at 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Orlando, FL, 07 December 2019 - 10 December 2019, http://dx.doi.org/10.1182/blood-2019-127796
    Conference Papers | 2019
    Associate Professor Nada Hamad
    Bishop M; Flinn I; Borchmann P; Jaeger U; Westin J; Hamad N; Purtill D; Greil R; Thomas S; Teshima T; Harigae H; Garcia C; Barba P; Deol A; Shaughnessy P; Gu J; Andreola G; Prieto MM; Pacaud L; Schuster S, 2019, 'BELINDA : A phase 3 study evaluating the safety and efficacy of tisagenlecleucel versus standard of care in adult patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma', in JOURNAL FOR IMMUNOTHERAPY OF CANCER, BMC, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000496473200822&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2018
    Associate Professor Nada Hamad
    Maerevoet M; Vermaat J; Canales MA; Casasnovas R-O; Van den Neste E; Goy A; Hill BT; Thieblemont C; De Fatima De La Cruz M; Cavallo F; Follows G; Choquet S; Gurion R; Bouabdallah R; Jaeger U; Nagy A; Kuruvilla J; Warzocha K; Kalakonda N; Caimi P; Bakhshi S; Ku M; Hamad N; Veelken H; Matczak E; Ma X; Saint-Martin J-R; Shah JJ; Kauffman MG; Shacham S; Zijlstra JM, 2018, 'Single Agent Oral Selinexor Demonstrates Deep and Durable Responses in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) in Both GCB and Non GCB Subtypes: The Phase 2b Sadal Study', in BLOOD, AMER SOC HEMATOLOGY, San Diego, CA, presented at 60th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA, 01 December 2018 - 04 December 2018, http://dx.doi.org/10.1182/blood-2018-99-116868
    Conference Papers | 2018
    Associate Professor Nada Hamad
    Talaulikar D; Cochrane T; Gibson J; Hamad N; Ho PJ; Issa S; Fiona K; Lim JH; Simpson D; Tam C; Castillo JJ, 2018, 'Bing Neel Syndrome: Retrospective Australasian Experience of a Rare Treatable Complication of Waldenstrom Macroglobulinaemia/ Lymphoplasmacytic Lymphoma', in BLOOD, AMER SOC HEMATOLOGY, San Diego, CA, presented at 60th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA, 01 December 2018 - 04 December 2018, http://dx.doi.org/10.1182/blood-2018-99-113969
    Conference Abstracts | 2017
    Associate Professor Nada Hamad
    Thomson C; Hamad N; Moore J; Malouf M; Glanville A; Stone E, 2017, 'PULMONARY GRAFT VERSUS HOST DISEASE ASSESSMENT OF LOCAL SCREENING AND DIAGNOSTIC PRACTICES', in RESPIROLOGY, WILEY, Vol. 22, pp. 167 - 167, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000396791000309&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2017
    Associate Professor Nada Hamad
    Hamad N; Rahman SMM; Islam MS, 2017, 'Novel Remote Authentication Protocol Using Heart-signals with Chaos Cryptography', in 2017 INTERNATIONAL CONFERENCE ON INFORMATICS, HEALTH & TECHNOLOGY (ICIHT), IEEE, Riyadh, SAUDI ARABIA, presented at International Conference on Informatics, Health and Technology (ICIHT), Riyadh, SAUDI ARABIA, 21 February 2017 - 23 February 2017, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000403395000024&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2015
    Associate Professor Nada Hamad
    Uhm J; Zheng Q; Cao J; Hamad N; Kim HJ; Moon JH; Sohn SK; Jung CW; Lipton JH; Kim DDH, 2015, 'SINGLE NUCLEOTIDE POLYMORPHISMS IN APOPTOSIS PATHWAY ARE ASSOCIATED WITH RESPONSE TO IMATINIB THERAPY IN CHRONIC MYELOID LEUKEMIA', in HAEMATOLOGICA, FERRATA STORTI FOUNDATION, Vienna, AUSTRIA, pp. 428 - 428, presented at 20th Congress of European-Hematology-Association, Vienna, AUSTRIA, 11 June 2015 - 14 June 2015, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000361204903060&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2014
    Associate Professor Nada Hamad
    Martell MP; Hamad N; Michelis FV; Uhm J; Alfraih F; Shanavas M; Gupta V; Kuruvilla J; Lipton JH; Messner HA; Seftel MD; Kim D, 2014, 'HCT-CI Has Prognostic Value in Acute, but Not Chronic Gvhd Specific Survival', in BLOOD, AMER SOC HEMATOLOGY, San Francisco, CA, presented at 56th Annual Meeting of the American-Society-of-Hematology, San Francisco, CA, 06 December 2014 - 09 December 2014, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000349233805134&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2014
    Associate Professor Nada Hamad
    Uhm J; Hamad N; Shin EM; Gupta V; Kuruvilla J; Lipton JH; Messner HA; Seftel M; Kim DDH, 2014, 'The NIH Chronic Gvhd Global Score and the CIBMTR Risk Score Correlate Well with Failure Free Survival Following Frontline Systemic Corticosteroid Therapy for Chronic Gvhd', in BLOOD, AMER SOC HEMATOLOGY, San Francisco, CA, presented at 56th Annual Meeting of the American-Society-of-Hematology, San Francisco, CA, 06 December 2014 - 09 December 2014, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000349243503114&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2014
    Associate Professor Nada Hamad
    Uhm J; Hamad N; Gupta V; Kuruvilla J; Messner HA; Seftel M; Lipton JH; Kim DD, 2014, 'The Risk Factors for IgG Hypogammaglobulinemia after Allogeneic Hematopoietic Stem Cell Transplantation and Its Impact on Transplant Outcomes', in BLOOD, AMER SOC HEMATOLOGY, San Francisco, CA, presented at 56th Annual Meeting of the American-Society-of-Hematology, San Francisco, CA, 06 December 2014 - 09 December 2014, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000349233801079&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2014
    Associate Professor Nada Hamad
    Uhm J; Hamad N; Michelis FV; Shanavas M; Kuruvilla J; Gupta V; Lipton JH; Messner HA; Seftel M; Kim DD, 2014, 'The risk of polyomavirus BK-associated hemorrhagic cystitis after allogeneic hematopoietic SCT is associated with myeloablative conditioning, CMV viremia and severe acute GVHD', in Bone Marrow Transplantation, pp. 1528 - 1534, http://dx.doi.org/10.1038/bmt.2014.181
    Conference Papers | 2014
    Associate Professor Nada Hamad
    Sibai H; Michelis FV; Hamad N; Uhm J; Gupta V; Kuruvilla JG; Lipton JH; Messner HA; Seftel MD; Kim DDH, 2014, 'Propensity Score Matching Analysis Comparing Reduced Intensity Versus Myeloablative Conditioning in AML/MDS Patients Transplanted with Fludarabine-Busulfan-Low Dose Total Body Irradiation Based Regimen', in BLOOD, AMER SOC HEMATOLOGY, San Francisco, CA, presented at 56th Annual Meeting of the American-Society-of-Hematology, San Francisco, CA, 06 December 2014 - 09 December 2014, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000349243503083&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2013
    Associate Professor Nada Hamad
    Uhm J; Hamad N; Shanavas M; Michelis FV; Gupta V; Kuruvilla J; Messner HA; Lipton JH; Kim DDH, 2013, 'Incidence, Risk Factors and Allogeneic Stem Cell Transplant Outcomes In Chronic Sclerotic Gvhd: T-Cell Depletion Is Preventive and Peripheral Blood Stem Cellis a Risk Factor, But Not HLA-Mismatch With No Adverse Impact On Transplant Outcomes', in BLOOD, AMER SOC HEMATOLOGY, New Orleans, LA, presented at 55th Annual Meeting of the American-Society-of-Hematology, New Orleans, LA, 07 December 2013 - 10 December 2013, http://dx.doi.org/10.1182/blood.V122.21.3293.3293
    Conference Papers | 2013
    Associate Professor Nada Hamad
    Hamad N; Shanavas M; Michelis FV; Uhm J; Gupta V; Kuruvilla J; Lipton JH; Messner HA; Kim D, 2013, 'Mycophenolate Compared to Methotrexate As Part of Cyclosporine Based-GVHD Prophylaxis Does Not Affect Transplant Outcomes, Reduces Organ Specific Acute And Chronic GVHD, but Increases The Risk of CMV Viremia In Matched Related Donor Peripheral Blood Stem Cell Transplantation', in BLOOD, AMER SOC HEMATOLOGY, New Orleans, LA, presented at 55th Annual Meeting of the American-Society-of-Hematology, New Orleans, LA, 07 December 2013 - 10 December 2013, http://dx.doi.org/10.1182/blood.V122.21.3303.3303
    Conference Papers | 2013
    Associate Professor Nada Hamad
    Hamad N; Del Bel R; Messner HA; Kim D; Kuruvilla J; Lipton JH; Uhm J; Xu W; Gupta V, 2013, 'Outcomes of Allogeneic Hematopoietic Cell Transplantation In Aplastic Anemia Using Intermediate Dose Alemtuzumab Based-Conditioning', in BLOOD, AMER SOC HEMATOLOGY, New Orleans, LA, presented at 55th Annual Meeting of the American-Society-of-Hematology, New Orleans, LA, 07 December 2013 - 10 December 2013, http://dx.doi.org/10.1182/blood.V122.21.2044.2044
    Conference Papers | 2013
    Associate Professor Nada Hamad
    Uhm J; Hamad N; Shanavas M; Michelis FV; Gupta V; Kuruvilla J; Messner HA; Lipton JH; Kim D, 2013, 'The Risk Of BK Virus Haemorrhagic Cystitis After Allogeneic Hematopoietic Stem Cell Transplantation Is Increased With Myeloablative Conditioning, CMV Viremia and Acute Gvhd', in BLOOD, AMER SOC HEMATOLOGY, New Orleans, LA, presented at 55th Annual Meeting of the American-Society-of-Hematology, New Orleans, LA, 07 December 2013 - 10 December 2013, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000331385007053&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Awards

Grants

Media